US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLIMB BIO INC

14.25

-0.7000-4.68%

Volume:1.38M

Turnover:19.95M

Market Cap:815.96M

PE:-17.07

High:15.45

Open:15.21

Low:14.09

Close:14.95

52wk High:18.33

52wk Low:1.54

Shares:57.26M

Float Shares:41.60M

Volume Ratio:0.62

T/O Rate:3.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8347

EPS(LYR):-0.8974

ROE:-27.10%

ROA:-18.45%

PB:3.41

PE(LYR):-15.88

Loading ...

Overview Company News Filings

Climb Bio Names Breanna O’reilly to Board After Andrew Levin Resigns

Climb Bio Price Target Maintained with a $20.00/share by HC Wainwright & Co.

Tango Therapeutics appoints Robert Azelby to board of directors

BRIEF-Climb Bio - Enters Open Market Sale Agreement With Jefferies - SEC Filing

Climb Bio enters Jefferies ATM equity distribution agreement for up to $100 million stock sale

Climb Bio - Enters Open Market Sale Agreement With Jefferies Dated June 12, 2026 - SEC Filing

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM)

Climb Bio price target raised to $20 from $19 at BTIG

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR) and Climb Bio (CLYM)

Climb Bio Is Maintained at Buy by BTIG

Climb Bio reports initial Phase 1b data showing platelet responses for budoprutug in immune thrombocytopenia trial

Climb Bio - Announces Initial Phase 1B Data for Budoprutug in Immune Thrombocytopenia

THOMSON REUTERS

Climb Bio - Enrollment Ongoing in 1000 Mg Cohort With Data Expected by Year-End 2026

THOMSON REUTERS

Climb Bio sets 5,216,105-share cap under 2021 equity incentive plan

Climb Bio initiated with a Buy at Guggenheim

Guggenheim Initiates Climb Bio at Buy With $35 Price Target

MT Newswires Live

Climb Bio Price Target Maintained With a $19.00/Share by BTIG

Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Climb Bio (CLYM)

BRIEF-Climb Bio - Announces Initial Phase 1 Safety Data For CLYM116 - SEC Filing

Climb Bio - No Serious Adverse Events or Dose Limiting Toxicities Observed for Clym116 in Phase 1 - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/CLYM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CLYM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":14.25,"timestamp":1789156800000,"preClose":14.95,"halted":0,"volume":1378431,"delay":0,"changeRate":-0.04682274247491634,"floatShares":41603800,"shares":57260500,"eps":-0.83475,"marketStatus":"Pre-Mkt","change":-0.7,"latestTime":"09-14 06:30:19 EDT","open":15.21,"high":15.445,"low":14.09,"amount":19954747.475451,"amplitude":0.090635,"askPrice":14.42,"askSize":30,"bidPrice":12.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.83475,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":14.25,"postHourTrading":{"tag":"盘后","latestPrice":14.48,"preClose":14.25,"latestTime":"19:30 EDT","volume":16919,"amount":241153.5116,"timestamp":1789169407048,"change":0.23,"changeRate":0.01614,"amplitude":0.01614},"volumeRatio":0.622581082578815,"impliedVol":1.1949,"impliedVolPercentile":0.4783},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","floatShares":41603800,"roa":"-18.45%","roe":"-27.10%","lyrEps":-0.897422,"volumeRatio":0.622581082578815,"shares":57260500,"dividePrice":0,"high":15.445,"amplitude":0.090635,"preClose":14.95,"low":14.09,"week52Low":1.54,"pbRate":"3.41","week52High":18.33,"institutionHeld":0,"latestPrice":14.25,"committee":0.538462,"eps":-0.83475,"divideRate":0,"volume":1378431,"delay":0,"ttmEps":-0.83475,"open":15.21,"prevYearClose":4,"prevWeekClose":14.25,"prevMonthClose":13.73,"prevQuarterClose":13.04,"fiveDayClose":14.59,"twentyDayClose":14.73,"sixtyDayClose":10.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLYM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"CLYM","fiscalQuarterEnding":"2026/06","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2026-05-07","symbol":"CLYM","fiscalQuarterEnding":"2026/03","expectedEps":-0.26,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2026-03-05","symbol":"CLYM","fiscalQuarterEnding":"2025/12","expectedEps":-0.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"CLYM","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"CLYM","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLYM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLYM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5333,"buy":0.4667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5333,"analysts":15,"updateTime":1785816000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLYM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLYM","date":"2026-09-11","current":-17.070979,"percent":0.03527,"low":-17.781875,"twenty":-7.140021,"median":-3.141297,"eighty":-1.264299,"high":-0.85032,"avg":-4.831808,"sd":4.31753,"marketCap":858672012},"quantilePoints":[{"date":"2024-10-04","current":-5.327624,"twenty":-5.327624,"median":-5.327624,"eighty":-5.327624,"marketCap":342006831},{"date":"2024-10-11","current":-5.369409,"twenty":-5.463426,"median":-5.390302,"eighty":-5.369409,"marketCap":344689237},{"date":"2024-10-18","current":-5.076912,"twenty":-5.494765,"median":-5.390302,"eighty":-5.327624,"marketCap":325912392},{"date":"2024-10-25","current":-4.85754,"twenty":-5.463426,"median":-5.327624,"eighty":-5.014234,"marketCap":311829757},{"date":"2024-10-31","current":-4.094958,"twenty":-5.404927,"median":-5.238831,"eighty":-4.776059,"marketCap":262875838},{"date":"2024-11-08","current":-3.677105,"twenty":-5.390302,"median":-5.014234,"eighty":-4.074065,"marketCap":236051773},{"date":"2024-11-15","current":-3.107258,"twenty":-5.373588,"median":-4.888879,"eighty":-3.806639,"marketCap":214779913},{"date":"2024-11-22","current":-2.917613,"twenty":-5.335981,"median":-4.293438,"eighty":-3.619939,"marketCap":201671280},{"date":"2024-11-29","current":-3.141297,"twenty":-5.327624,"median":-4.220314,"eighty":-3.127681,"marketCap":217132744},{"date":"2024-12-06","current":-2.830085,"twenty":-5.277482,"median":-3.974826,"eighty":-3.040153,"marketCap":195621141},{"date":"2024-12-13","current":-2.742557,"twenty":-5.237786,"median":-3.781569,"eighty":-2.995417,"marketCap":189571003},{"date":"2024-12-20","current":-1.896449,"twenty":-5.13959,"median":-3.671882,"eighty":-2.96235,"marketCap":131086332},{"date":"2024-12-27","current":-2.207661,"twenty":-5.051841,"median":-3.301766,"eighty":-2.921503,"marketCap":152597935},{"date":"2025-01-03","current":-2.013153,"twenty":-5.003788,"median":-3.151022,"eighty":-2.57139,"marketCap":139153183},{"date":"2025-01-10","current":-1.818646,"twenty":-4.962003,"median":-3.124277,"eighty":-2.236837,"marketCap":125708431},{"date":"2025-01-17","current":-1.954801,"twenty":-4.920218,"median":-3.063494,"eighty":-2.032604,"marketCap":135119757},{"date":"2025-01-24","current":-1.770019,"twenty":-4.870076,"median":-3.005142,"eighty":-1.952856,"marketCap":122347243},{"date":"2025-01-31","current":-1.876998,"twenty":-4.531614,"median":-2.995417,"eighty":-1.91979,"marketCap":129741856},{"date":"2025-02-07","current":-1.701941,"twenty":-4.324777,"median":-2.96624,"eighty":-1.892559,"marketCap":117641580},{"date":"2025-02-14","current":-1.546335,"twenty":-4.251653,"median":-2.932201,"eighty":-1.865328,"marketCap":106885778},{"date":"2025-02-21","current":-1.400454,"twenty":-4.228671,"median":-2.873849,"eighty":-1.840042,"marketCap":96802214},{"date":"2025-02-28","current":-1.351828,"twenty":-4.1451,"median":-2.528598,"eighty":-1.818646,"marketCap":93441026},{"date":"2025-03-07","current":-1.429631,"twenty":-4.03228,"median":-2.256288,"eighty":-1.756403,"marketCap":98818927},{"date":"2025-03-14","current":-1.293475,"twenty":-3.971692,"median":-2.18821,"eighty":-1.542445,"marketCap":89407600},{"date":"2025-03-21","current":-1.244848,"twenty":-3.871407,"median":-2.022879,"eighty":-1.474368,"marketCap":86046412},{"date":"2025-03-28","current":-1.159638,"twenty":-3.794104,"median":-1.954801,"eighty":-1.429631,"marketCap":85693751},{"date":"2025-04-04","current":-1.050066,"twenty":-3.724618,"median":-1.940213,"eighty":-1.381004,"marketCap":77596704},{"date":"2025-04-11","current":-1.059197,"twenty":-3.680923,"median":-1.925625,"eighty":-1.357663,"marketCap":78271458},{"date":"2025-04-17","current":-1.150507,"twenty":-3.672927,"median":-1.896449,"eighty":-1.324596,"marketCap":85018997},{"date":"2025-04-25","current":-1.187031,"twenty":-3.573219,"median":-1.876998,"eighty":-1.28764,"marketCap":87718013},{"date":"2025-05-02","current":-1.150507,"twenty":-3.328025,"median":-1.867273,"eighty":-1.252628,"marketCap":85018997},{"date":"2025-05-09","current":-1.088206,"twenty":-3.166583,"median":-1.847822,"eighty":-1.218825,"marketCap":80415162},{"date":"2025-05-16","current":-0.872124,"twenty":-3.152968,"median":-1.818646,"eighty":-1.187031,"marketCap":81090920},{"date":"2025-05-23","current":-0.872124,"twenty":-3.141297,"median":-1.818646,"eighty":-1.164325,"marketCap":81090920},{"date":"2025-05-30","current":-0.886659,"twenty":-3.134489,"median":-1.784607,"eighty":-1.159638,"marketCap":82442435},{"date":"2025-06-06","current":-0.901194,"twenty":-3.10434,"median":-1.750568,"eighty":-1.150507,"marketCap":83793951},{"date":"2025-06-13","current":-0.930265,"twenty":-3.086835,"median":-1.590099,"eighty":-1.125277,"marketCap":86496981},{"date":"2025-06-20","current":-0.893927,"twenty":-3.063494,"median":-1.522022,"eighty":-1.106495,"marketCap":83118193},{"date":"2025-06-27","current":-0.91573,"twenty":-3.014867,"median":-1.478258,"eighty":-1.095721,"marketCap":85145466},{"date":"2025-07-03","current":-0.930265,"twenty":-3.007087,"median":-1.439356,"eighty":-1.066502,"marketCap":86496981},{"date":"2025-07-11","current":-0.981139,"twenty":-2.997362,"median":-1.429631,"eighty":-1.007303,"marketCap":91227285},{"date":"2025-07-18","current":-1.061084,"twenty":-2.995417,"median":-1.400454,"eighty":-0.995674,"marketCap":98660619},{"date":"2025-07-25","current":-1.075619,"twenty":-2.995417,"median":-1.376141,"eighty":-1.007303,"marketCap":100012135},{"date":"2025-08-01","current":-1.017477,"twenty":-2.979856,"median":-1.361553,"eighty":-1.016024,"marketCap":94606073},{"date":"2025-08-08","current":-1.220973,"twenty":-2.968185,"median":-1.346965,"eighty":-1.017477,"marketCap":113527288},{"date":"2025-08-15","current":-2.492713,"twenty":-2.95846,"median":-1.351828,"eighty":-1.023291,"marketCap":116554252},{"date":"2025-08-22","current":-3.173861,"twenty":-2.979856,"median":-1.366416,"eighty":-1.024745,"marketCap":148403379},{"date":"2025-08-29","current":-3.333278,"twenty":-3.007087,"median":-1.381004,"eighty":-1.030392,"marketCap":155857430},{"date":"2025-09-05","current":-3.376756,"twenty":-3.075164,"median":-1.400454,"eighty":-1.031929,"marketCap":157890353},{"date":"2025-09-12","current":-3.478204,"twenty":-3.149077,"median":-1.429631,"eighty":-1.042845,"marketCap":162633840},{"date":"2025-09-19","current":-3.246323,"twenty":-3.164638,"median":-1.439356,"eighty":-1.052316,"marketCap":151791584},{"date":"2025-09-26","current":-3.043428,"twenty":-3.197049,"median":-1.483121,"eighty":-1.053816,"marketCap":142304610},{"date":"2025-10-03","current":-2.956473,"twenty":-3.173861,"median":-1.53661,"eighty":-1.057045,"marketCap":138238764},{"date":"2025-10-10","current":-2.739085,"twenty":-3.171828,"median":-1.667902,"eighty":-1.060329,"marketCap":128074149},{"date":"2025-10-17","current":-2.82604,"twenty":-3.164638,"median":-1.760293,"eighty":-1.06543,"marketCap":132139995},{"date":"2025-10-24","current":-2.88401,"twenty":-3.171828,"median":-1.808921,"eighty":-1.072703,"marketCap":134850559},{"date":"2025-10-31","current":-2.88401,"twenty":-3.164638,"median":-1.818646,"eighty":-1.075619,"marketCap":134850559},{"date":"2025-11-07","current":-2.603692,"twenty":-3.149077,"median":-1.838097,"eighty":-1.083171,"marketCap":132139995},{"date":"2025-11-14","current":-2.512362,"twenty":-3.141297,"median":-1.857547,"eighty":-1.088206,"marketCap":127504893},{"date":"2025-11-21","current":-2.324271,"twenty":-3.120874,"median":-1.876998,"eighty":-1.092715,"marketCap":117959072},{"date":"2025-11-28","current":-2.539232,"twenty":-3.101423,"median":-1.886723,"eighty":-1.096373,"marketCap":128868582},{"date":"2025-12-05","current":-2.324271,"twenty":-3.090364,"median":-1.896449,"eighty":-1.097379,"marketCap":117959072},{"date":"2025-12-12","current":-3.090071,"twenty":-3.088805,"median":-1.930487,"eighty":-1.097422,"marketCap":156824200},{"date":"2025-12-19","current":-5.88457,"twenty":-3.141297,"median":-1.945076,"eighty":-1.098568,"marketCap":298647825},{"date":"2025-12-26","current":-4.562679,"twenty":-3.173183,"median":-1.969389,"eighty":-1.101167,"marketCap":231560509},{"date":"2026-01-02","current":-3.763034,"twenty":-3.231831,"median":-2.032604,"eighty":-1.10469,"marketCap":190977740},{"date":"2026-01-09","current":-4.308674,"twenty":-3.260816,"median":-2.195782,"eighty":-1.104852,"marketCap":218669512},{"date":"2026-01-16","current":-3.54666,"twenty":-3.333278,"median":-2.236837,"eighty":-1.106495,"marketCap":179996519},{"date":"2026-01-23","current":-4.619124,"twenty":-3.365162,"median":-2.283966,"eighty":-1.112485,"marketCap":234425175},{"date":"2026-01-30","current":-4.496826,"twenty":-3.449218,"median":-2.324271,"eighty":-1.121288,"marketCap":228218399},{"date":"2026-02-06","current":-4.374527,"twenty":-3.488132,"median":-2.337706,"eighty":-1.123114,"marketCap":222011622},{"date":"2026-02-13","current":-4.957797,"twenty":-3.580579,"median":-2.363428,"eighty":-1.131766,"marketCap":251613172},{"date":"2026-02-20","current":-5.305878,"twenty":-3.670837,"median":-2.397337,"eighty":-1.138397,"marketCap":269278613},{"date":"2026-02-27","current":-6.942798,"twenty":-3.770448,"median":-2.418317,"eighty":-1.146855,"marketCap":352353930},{"date":"2026-03-06","current":-5.895163,"twenty":-3.911674,"median":-2.457761,"eighty":-1.150507,"marketCap":352831374},{"date":"2026-03-13","current":-5.794315,"twenty":-4.006508,"median":-2.512362,"eighty":-1.150507,"marketCap":346795534},{"date":"2026-03-20","current":-5.570843,"twenty":-4.127762,"median":-2.533915,"eighty":-1.150507,"marketCap":333420500},{"date":"2026-03-27","current":-5.674598,"twenty":-4.262099,"median":-2.552667,"eighty":-1.150507,"marketCap":339630337},{"date":"2026-04-02","current":-5.546899,"twenty":-4.40275,"median":-2.552667,"eighty":-1.154159,"marketCap":331987461},{"date":"2026-04-10","current":-6.424826,"twenty":-4.493063,"median":-2.591615,"eighty":-1.159638,"marketCap":384532239},{"date":"2026-04-17","current":-7.039457,"twenty":-4.68874,"median":-2.608653,"eighty":-1.159638,"marketCap":421318549},{"date":"2026-04-24","current":-7.199082,"twenty":-4.833617,"median":-2.724593,"eighty":-1.160328,"marketCap":430872257},{"date":"2026-05-01","current":-7.087345,"twenty":-4.902724,"median":-2.742557,"eighty":-1.16195,"marketCap":424184661},{"date":"2026-05-08","current":-9.505662,"twenty":-5.051841,"median":-2.788531,"eighty":-1.165206,"marketCap":568923347},{"date":"2026-05-15","current":-10.251886,"twenty":-5.174172,"median":-2.811548,"eighty":-1.168769,"marketCap":541217592},{"date":"2026-05-22","current":-9.871852,"twenty":-5.232411,"median":-2.842555,"eighty":-1.168769,"marketCap":521154804},{"date":"2026-05-29","current":-10.260935,"twenty":-5.270935,"median":-2.876764,"eighty":-1.172421,"marketCap":541695277},{"date":"2026-06-05","current":-9.871852,"twenty":-5.327624,"median":-2.88401,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-12","current":-9.871852,"twenty":-5.377318,"median":-2.898503,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-18","current":-12.299862,"twenty":-5.428177,"median":-2.912995,"eighty":-1.187031,"marketCap":649334330},{"date":"2026-06-26","current":-13.731592,"twenty":-5.484622,"median":-2.927339,"eighty":-1.196162,"marketCap":724918221},{"date":"2026-07-02","current":-14.414918,"twenty":-5.570843,"median":-2.937064,"eighty":-1.198568,"marketCap":760992350},{"date":"2026-07-10","current":-14.989779,"twenty":-5.662848,"median":-2.956494,"eighty":-1.212372,"marketCap":791340427},{"date":"2026-07-17","current":-13.644821,"twenty":-5.682623,"median":-2.970966,"eighty":-1.219913,"marketCap":720337379},{"date":"2026-07-24","current":-13.840057,"twenty":-5.734417,"median":-2.990438,"eighty":-1.223039,"marketCap":730644273},{"date":"2026-07-31","current":-13.102499,"twenty":-5.816662,"median":-2.995417,"eighty":-1.223555,"marketCap":691707117},{"date":"2026-08-07","current":-13.912299,"twenty":-5.930387,"median":-3.014443,"eighty":-1.230727,"marketCap":801682322},{"date":"2026-08-14","current":-14.682008,"twenty":-6.54289,"median":-3.029148,"eighty":-1.235508,"marketCap":846036036},{"date":"2026-08-21","current":-16.964547,"twenty":-6.686846,"median":-3.057921,"eighty":-1.239293,"marketCap":977565060},{"date":"2026-08-28","current":-15.010933,"twenty":-6.894117,"median":-3.079659,"eighty":-1.243636,"marketCap":864990000},{"date":"2026-09-04","current":-14.542464,"twenty":-7.049001,"median":-3.09267,"eighty":-1.256519,"marketCap":837994960},{"date":"2026-09-11","current":-14.901291,"twenty":-7.140021,"median":-3.141297,"eighty":-1.264299,"marketCap":858672012}],"updateTime":1789381819469},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLYM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648526669","title":"Climb Bio Names Breanna O’reilly to Board After Andrew Levin Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2648526669","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648526669?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:18","pubTimestamp":1782937101,"startTime":"0","endTime":"0","summary":"Climb Bio names Breanna O’Reilly to board after Andrew Levin resignsClimb Bio reshaped its board on June 29, 2026, following the resignation of director Andrew Levin, effective immediately.Breanna O'R","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL5tgR0d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889225","title":"Climb Bio Price Target Maintained with a $20.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889225","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645889225?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:00","pubTimestamp":1782298800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 07:00 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645707714","title":"Tango Therapeutics appoints Robert Azelby to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2645707714","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645707714?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:05","pubTimestamp":1782158746,"startTime":"0","endTime":"0","summary":"Tango Therapeutics appointed biopharmaceutical executive Robert Azelby to its board as it advances PRMT5 inhibitor vopimetostat toward potential late-stage pancreatic cancer development.Azelby previously led Eliem Therapeutics as CEO, ran Alder BioPharmaceuticals through its sale to H. Lundbeck, served as Juno Therapeutics’ chief commercial officer.He also spent 15 years at Amgen, ending as vice president and general manager of oncology overseeing a $6 billion portfolio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLc0HXqp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU1983299246.USD","IE00BGHQF748.EUR","BK4112","LU1868837300.USD","IE00BFXG1179.USD","LU0985481810.HKD","IE0002141913.USD","LU1585245621.USD","LU1061106388.HKD","BK4007","LU0314104364.USD","LU1989771016.USD","BK4139","LU2210149790.SGD","LU0321505439.SGD","BK4539","NDAQ","LU0306806265.USD","LU1093756325.SGD","IE00BN0W2T93.GBP","LU2089984988.USD","LU1670711040.USD","CLYM","LU0109394709.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU2125154935.USD","IE00BSNM7G36.USD","LU1323610961.USD","LU2125154778.USD","IE00B4R5TH58.HKD","LU2360032135.SGD","LU1093756168.USD","IE00B2B36J28.USD","BMY","BK4581","LU0225284248.USD","BK4534","BK4566","TNGX","BK4559","BK4599","LU0432979614.USD","LU0114720955.EUR","BK4532","AMGN","LU1291159041.SGD","SG9999014005.SGD","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643589213","title":"BRIEF-Climb Bio - Enters Open Market Sale Agreement With Jefferies - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643589213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643589213?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:01","pubTimestamp":1781298063,"startTime":"0","endTime":"0","summary":"BRIEF-Climb Bio - Enters Open Market Sale Agreement With Jefferies - SEC FilingJune 12  - Climb Bio Inc CLYM.O:CLIMB BIO - ENTERS OPEN MARKET SALE AGREEMENT WITH JEFFERIES - SEC FILINGCLIMB BIO - MAY OFFER AND SELL UP TO $100 MILLION OF COMMON STOCK - SEC FILINGSource text: [ID:n0001193125-26-269567]Further company coverage: CLYM.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643428218","title":"Climb Bio enters Jefferies ATM equity distribution agreement for up to $100 million stock sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2643428218","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643428218?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:37","pubTimestamp":1781296641,"startTime":"0","endTime":"0","summary":"Climb Bio entered an at-the-market equity distribution agreement with Jefferies for up to USD 100 million of common stock.Jefferies will act as sales agent with up to 3% commission on shares sold.The prior ATM program with Oppenheimer was terminated effective June 11, 2026; no shares were sold under that program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL1v9n1L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643185732","title":"Climb Bio - Enters Open Market Sale Agreement With Jefferies Dated June 12, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643185732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643185732?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:24","pubTimestamp":1781295874,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642293126","title":"Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642293126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642293126?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:50","pubTimestamp":1781268613,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-united-therapeutics-uthr-dentsply-sirona-xray-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-united-therapeutics-uthr-dentsply-sirona-xray-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XRAY","BK4137","XBI","LU0128526141.USD","BK4585","BK4198","BK4539","CLYM","LU0029874061.USD","UTHR","BK4581","BK4532","LABU","HCSG","BK4588","XLV","BK4139","LU1571399168.USD","LU1699723380.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642235488","title":"Climb Bio price target raised to $20 from $19 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2642235488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642235488?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:26","pubTimestamp":1781195203,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison raised the firm’s price target on Climb Bio (CLYM) to $20 from $19 and keeps a Buy rating on the shares. Budoprutug, a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-20-from-19-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-20-from-19-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642323568","title":"Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR) and Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642323568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642323568?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:00","pubTimestamp":1781193648,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Schrodinger (SDGR) and Climb Bio (CLYM) with bullish...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-schrodinger-sdgr-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-schrodinger-sdgr-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4167","BK4137","BK4139","CLYM","XLV","LU0029874061.USD","LABU","LU0128526141.USD","BK4581","HCSG","SDGR","BK4539","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642233444","title":"Climb Bio Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2642233444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642233444?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:52","pubTimestamp":1781193120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2026 11:52 ET (15:52 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642210286","title":"Climb Bio reports initial Phase 1b data showing platelet responses for budoprutug in immune thrombocytopenia trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642210286","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642210286?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:02","pubTimestamp":1781175746,"startTime":"0","endTime":"0","summary":"Climb Bio presented initial Phase 1b data at EHA Congress 2026 for budoprutug in primary immune thrombocytopenia.Early results showed favorable safety and tolerability, with no serious safety signals reported in the cohorts disclosed.The study showed clear biological activity, with B-cell suppression and meaningful, durable platelet responses in heavily pretreated patients.Responses were observed in some patients previously treated with rituximab, supporting potential differentiation in a hard-to-treat population.Enrollment continues in the high-dose cohort, with additional data expected by year-end 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLbmtmjp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CLYM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642861322","title":"Climb Bio - Announces Initial Phase 1B Data for Budoprutug in Immune Thrombocytopenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2642861322","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642861322?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:00","pubTimestamp":1781175651,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CLYM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642286164","title":"Climb Bio - Enrollment Ongoing in 1000 Mg Cohort With Data Expected by Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2642286164","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642286164?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:00","pubTimestamp":1781175651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J01I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431571","title":"Climb Bio sets 5,216,105-share cap under 2021 equity incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431571?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:08","pubTimestamp":1780949321,"startTime":"0","endTime":"0","summary":"Climb Bio adopted a 2021 Equity Incentive Plan, effective immediately before its IPO date, replacing the 2019 plan for new grants.Share pool set at 5,216,105 shares, including 2,558,790 new shares, with up to 2,657,315 shares recycled from the prior plan.Automatic annual increases set at 5% of shares outstanding from Jan. 1, 2022 through Jan. 1, 2026, subject to board reduction.Non-employee director pay capped at USD 750,000 per year, rising to USD 1 million for a director first appointed or elected that year.Options or SARs carry a maximum 10-year term, with post-termination exercise windows of 3 months, 12 months for disability, 18 months for death.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL9jNgdG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489520","title":"Climb Bio initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489520?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:16","pubTimestamp":1780917389,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Climb Bio (CLYM) with a Buy rating and $35 price target. Lead asset budoprutug is delivering deep B-cell depletion...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/climb-bio-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/climb-bio-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBB","BK4539","CLYM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641483029","title":"Guggenheim Initiates Climb Bio at Buy With $35 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2641483029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641483029?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:19","pubTimestamp":1780913990,"startTime":"0","endTime":"0","summary":"Climb Bio (CLYM) has an average rating of buy and mean price target of $19.77, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641488412","title":"Climb Bio Price Target Maintained With a $19.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2641488412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641488412?lang=en_us&edition=fundamental","pubTime":"2026-06-08 17:49","pubTimestamp":1780912140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 08, 2026 05:49 ET (09:49 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641142272","title":"Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641142272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641142272?lang=en_us&edition=fundamental","pubTime":"2026-06-06 03:10","pubTimestamp":1780686611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on RegenXBio (RGNX) and Climb Bio (CLYM) with bullish s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4505","CLYM","BK4563","RGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641117374","title":"BRIEF-Climb Bio - Announces Initial Phase 1 Safety Data For CLYM116 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641117374","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641117374?lang=en_us&edition=fundamental","pubTime":"2026-06-05 19:18","pubTimestamp":1780658296,"startTime":"0","endTime":"0","summary":"BRIEF-Climb Bio - Announces Initial Phase 1 Safety Data For CLYM116 - SEC FilingJune 5  - Climb Bio Inc CLYM.O:CLIMB BIO - ANNOUNCES INITIAL PHASE 1 SAFETY DATA FOR CLYM116 - SEC FILINGCLIMB BIO - NO SERIOUS ADVERSE EVENTS OR DOSE LIMITING TOXICITIES OBSERVED FOR CLYM116 IN PHASE 1 - SEC FILINGFurther company coverage: CLYM.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D08X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641117806","title":"Climb Bio - No Serious Adverse Events or Dose Limiting Toxicities Observed for Clym116 in Phase 1 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641117806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641117806?lang=en_us&edition=fundamental","pubTime":"2026-06-05 19:14","pubTimestamp":1780658080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D08X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":105,"code":"91000000","status":"200"}]}}